Winton Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,915
| Closed | -$1.16M | – | 603 |
|
|
2024
Q3 | $1.16M | Buy |
23,915
+1,681
| +8% | +$81.6K | 0.08% | 213 |
|
|
2024
Q2 | $889K | Buy |
22,234
+1,653
| +8% | +$66.1K | 0.06% | 340 |
|
|
2024
Q1 | $904K | Buy |
20,581
+12,514
| +155% | +$549K | 0.06% | 322 |
|
|
2023
Q4 | $499K | Sell |
8,067
-168
| -2% | -$10.4K | 0.04% | 316 |
|
|
2023
Q3 | $379K | Sell |
8,235
-1,624
| -16% | -$74.7K | 0.03% | 430 |
|
|
2023
Q2 | $567K | Sell |
9,859
-15,928
| -62% | -$915K | 0.05% | 272 |
|
|
2023
Q1 | $967K | Sell |
25,787
-5,831
| -18% | -$219K | 0.06% | 459 |
|
|
2022
Q4 | $886K | Buy |
31,618
+5,265
| +20% | +$148K | 0.06% | 450 |
|
|
2022
Q3 | $741K | Sell |
26,353
-3,288
| -11% | -$92.5K | 0.05% | 516 |
|
|
2022
Q2 | $1.03M | Buy |
29,641
+12,920
| +77% | +$449K | 0.05% | 478 |
|
|
2022
Q1 | $600K | Sell |
16,721
-19,574
| -54% | -$702K | 0.03% | 629 |
|
|
2021
Q4 | $845K | Sell |
36,295
-22,031
| -38% | -$513K | 0.05% | 516 |
|
|
2021
Q3 | $1.11M | Buy |
58,326
+4,574
| +9% | +$87K | 0.06% | 450 |
|
|
2021
Q2 | $1.08M | Buy |
53,752
+3,986
| +8% | +$80.4K | 0.06% | 487 |
|
|
2021
Q1 | $912K | Buy |
49,766
+2,581
| +5% | +$47.3K | 0.05% | 524 |
|
|
2020
Q4 | $949K | Sell |
47,185
-50,070
| -51% | -$1.01M | 0.07% | 431 |
|
|
2020
Q3 | $1.82M | Sell |
97,255
-101,065
| -51% | -$1.9M | 0.06% | 570 |
|
|
2020
Q2 | $4.45M | Buy |
198,320
+115,918
| +141% | +$2.6M | 0.11% | 266 |
|
|
2020
Q1 | $1.22M | Sell |
82,402
-10,276
| -11% | -$153K | 0.03% | 720 |
|
|
2019
Q4 | $1.79M | Buy |
92,678
+76,954
| +489% | +$1.48M | 0.03% | 837 |
|
|
2019
Q3 | $312K | Buy |
+15,724
| New | +$312K | ﹤0.01% | 1265 |
|
|
2019
Q2 | – | Sell |
-11,781
| Closed | -$241K | – | 1121 |
|
|
2019
Q1 | $241K | Buy |
+11,781
| New | +$241K | ﹤0.01% | 893 |
|